- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about XBI
Recent news which mentions XBI
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
From MarketWatch
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
From InvestorPlace
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
December 15, 2022
From MarketWatch
Look to SBIO for Biotech Exposure
December 12, 2022
From ETF Trends
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
November 22, 2022
From Benzinga
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
From Motley Fool
Chart of the Week: What Sector Looks Healthiest to Advisors
November 10, 2022
From ETF Trends
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
November 06, 2022
From Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
November 01, 2022
From Benzinga
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
From Motley Fool
My 3 Biggest Stock Market Predictions for October
October 11, 2022
From Motley Fool
SBIO Rallied While Major Indexes Declined Last Week
October 04, 2022
From ETF Trends
These long-duration bond ETFs have cratered the most from their peaks over past year, sinking below other assets as U.S. dollar soars
September 29, 2022
From MarketWatch
This ETF manager’s tactical models are ‘as bearish as they could possibly be’ as markets grapple with a ‘dangerous’ mix of rising rates and high inflation
September 22, 2022
From MarketWatch
SBIO Outpaced XBI, IBB in Volatile Last Week
September 21, 2022
From ETF Trends
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
From InvestorPlace
The Three Best Anti-Aging Stocks to Buy in September
September 19, 2022
From InvestorPlace
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
From InvestorPlace
Why Catalyst Pharmaceuticals Stock Marched Higher This Week
September 09, 2022
From Motley Fool
3 Money-Making Sectors House the Best Stocks to Buy Now
September 07, 2022
From InvestorPlace
Billionaire Joe Edelman’s biotech hedge fund hit with SEC charges for not disclosing SPAC conflicts
September 06, 2022
From MarketWatch
The Best Biotech Stock to Own in September
September 06, 2022
From Motley Fool
SBIO Was ALPS’ Top Performing ETF in August
September 01, 2022
From ETF Trends
From Benzinga
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
August 26, 2022
From MarketWatch
Biotech ETFs Are on the Mend
August 19, 2022
From ETF Trends
Biotech ETFs Slip After Novavax Cuts 2022 Guidance
August 10, 2022
From ETF Trends
SBIO Rallies on M&A Announcements
August 10, 2022
From ETF Trends
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.